Global Drugs for Malaria Competitive Landscape Professional Research Report 2024

Research Summary

Drugs for malaria encompass a range of medications used to treat and prevent malaria, a life-threatening mosquito-borne disease caused by parasites of the Plasmodium genus. These drugs include antimalarial agents like chloroquine, artemisinin-based combination therapies (ACTs), mefloquine, atovaquone-proguanil, and others. The choice of drug depends on the specific Plasmodium species causing the infection and its resistance patterns. Antimalarials work by targeting different stages of the parasite's lifecycle within the human body. They can cure active infections and also be used as prophylaxis to prevent infection for individuals traveling to or residing in malaria-endemic regions. Due to the development of drug-resistant strains of the malaria parasite, treatment strategies may change over time, and healthcare professionals often follow updated guidelines to ensure effective management of the disease.

According to DIResearch's in-depth investigation and research, the global Drugs for Malaria market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Sanofi Aventis, Novartis, Ajanta Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Drugs for Malaria. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drugs for Malaria market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drugs for Malaria market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drugs for Malaria industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Drugs for Malaria Include:

Cipla

Guilin Pharmaceutical

IPCA Laboratories

GlaxoSmithKline

Mylan Labs

Roche

Sanofi Aventis

Novartis

Ajanta Pharma

Drugs for Malaria Product Segment Include:

Aryl Aminoalcohol Compounds

Antifolate Compounds

Artemisinin Compounds

Drugs for Malaria Product Application Include:

Prevention

Treatment

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Drugs for Malaria Industry PESTEL Analysis

Chapter 3: Global Drugs for Malaria Industry Porter's Five Forces Analysis

Chapter 4: Global Drugs for Malaria Major Regional Market Size and Forecast Analysis

Chapter 5: Global Drugs for Malaria Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Drugs for Malaria Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Drugs for Malaria Market Overview

1.1 Product Definition and Statistical Scope

1.2 Drugs for Malaria Product by Type

1.2.1 Global Drugs for Malaria Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Aryl Aminoalcohol Compounds

1.2.3 Antifolate Compounds

1.2.4 Artemisinin Compounds

1.3 Drugs for Malaria Product by Application

1.3.1 Global Drugs for Malaria Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Prevention

1.3.3 Treatment

1.3.4 Others

1.4 Global Drugs for Malaria Market Revenue Analysis (2019-2030)

1.5 Drugs for Malaria Market Development Status and Trends

1.5.1 Drugs for Malaria Industry Development Status Analysis

1.5.2 Drugs for Malaria Industry Development Trends Analysis

2 Drugs for Malaria Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Drugs for Malaria Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Drugs for Malaria Market Analysis by Regions

4.1 Drugs for Malaria Overall Market: 2023 VS 2024 VS 2030

4.2 Global Drugs for Malaria Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Drugs for Malaria Revenue and Market Share by Region (2019-2024)

4.2.2 Global Drugs for Malaria Revenue Forecast by Region (2025-2030)

5 Global Drugs for Malaria Market Size by Type and Application

5.1 Global Drugs for Malaria Market Size by Type

5.2 Global Drugs for Malaria Market Size by Application

6 North America

6.1 North America Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Drugs for Malaria Market Size by Type

6.4 North America Drugs for Malaria Market Size by Application

6.5 North America Drugs for Malaria Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Drugs for Malaria Market Size by Type

7.4 Europe Drugs for Malaria Market Size by Application

7.5 Europe Drugs for Malaria Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Drugs for Malaria Market Size by Type

8.4 China Drugs for Malaria Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Drugs for Malaria Market Size by Type

9.4 APAC (excl. China) Drugs for Malaria Market Size by Application

9.5 APAC (excl. China) Drugs for Malaria Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Drugs for Malaria Market Size by Type

10.4 Latin America Drugs for Malaria Market Size by Application

10.5 Latin America Drugs for Malaria Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Drugs for Malaria Market Size by Type

11.4 Middle East & Africa Drugs for Malaria Market Size by Application

11.5 Middle East & Africa Drugs for Malaria Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Drugs for Malaria Market Revenue by Key Manufacturers (2020-2024)

12.2 Drugs for Malaria Competitive Landscape Analysis and Market Dynamic

12.2.1 Drugs for Malaria Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Cipla

13.1.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Cipla Drugs for Malaria Product Portfolio

13.1.3 Cipla Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Guilin Pharmaceutical

13.2.1 Guilin Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Guilin Pharmaceutical Drugs for Malaria Product Portfolio

13.2.3 Guilin Pharmaceutical Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 IPCA Laboratories

13.3.1 IPCA Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 IPCA Laboratories Drugs for Malaria Product Portfolio

13.3.3 IPCA Laboratories Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 GlaxoSmithKline

13.4.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 GlaxoSmithKline Drugs for Malaria Product Portfolio

13.4.3 GlaxoSmithKline Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Mylan Labs

13.5.1 Mylan Labs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Mylan Labs Drugs for Malaria Product Portfolio

13.5.3 Mylan Labs Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Roche

13.6.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Roche Drugs for Malaria Product Portfolio

13.6.3 Roche Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Sanofi Aventis

13.7.1 Sanofi Aventis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Sanofi Aventis Drugs for Malaria Product Portfolio

13.7.3 Sanofi Aventis Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Novartis

13.8.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Novartis Drugs for Malaria Product Portfolio

13.8.3 Novartis Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Ajanta Pharma

13.9.1 Ajanta Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Ajanta Pharma Drugs for Malaria Product Portfolio

13.9.3 Ajanta Pharma Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Drugs for Malaria Industry Chain Analysis

14.2 Drugs for Malaria Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Drugs for Malaria Typical Downstream Customers

14.4 Drugs for Malaria Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support